Diagnosis and management of inflammatory bowel disease
Journal of Evidence-Based Medicine · 2024-06 · 17 (2) · 409-433
DOI: 10.1111/jebm.12626 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Evidence-Based Medicine, online erschienen am 27.06.2024. Verfasst von Lili Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 220 Literaturangaben. Gefördert von: Sichuan International Science and Technology Innovation Cooperation/Hong Kong/Macao/Taiwan Science and Technology Innovation Cooperation Project, Sichuan International Science Foundation Project, Sichuan Science and Technology Program.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is a chronic and relapsing immune‐mediated disease of the gastrointestinal tract with a gradually increasing global incidence and prevalence. A prolonged course of IBD leads to a decline in patient quality of life and the creation of a substantial economic burden on society. Owing to the lack of specific diagnostic markers, the diagnosis of IBD still needs a gold standard based on a combination of clinical manifestations, imaging, laboratory, and endoscopic results. Accordingly, the current goals of IBD treatment are to alleviate clinical symptoms and reduce recurrence rates. Therefore, it is imperative to develop a standard set of procedures to diagnose and treat IBD. In this review, we summarize prominent and emerging studies, outline classical and contemporary approaches to diagnosing and managing IBD, and integrate multiple guidelines. Furthermore, we propose the possibility of establishing an early and comprehensive diagnostic workflow and personalized management strategy in the future. We aim to enhance the quality and standardization of diagnostic and treatment procedures for IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China.
- Centre for Inflammatory Bowel Disease, West China Hospital, Sichuan University, Chengdu, China.
- Lab of Inflammatory Bowel Disease, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
- The Center of Gerontology and Geriatrics, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.
ORCID-Profile: Hu Zhang
Förderung
- Sichuan International Science and Technology Innovation Cooperation/Hong Kong/Macao/Taiwan Science and Technology Innovation Cooperation Project
- Sichuan International Science Foundation Project
- Sichuan Science and Technology Program
- Project for disciplines of excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University
Zitieren
APA
Li, L., Cheng, R., Wu, Y., Lin, H., Gan, H., & Zhang, H. (2024). Diagnosis and management of inflammatory bowel disease. Journal of Evidence-Based Medicine, 17(2), 409-433. https://doi.org/10.1111/jebm.12626
Vancouver
Li L, Cheng R, Wu Y, Lin H, Gan H, Zhang H. Diagnosis and management of inflammatory bowel disease. Journal of Evidence-Based Medicine. 2024;17(2):409-433. doi:10.1111/jebm.12626
BibTeX
@article{Li2024,
author = {Li, Lili and Cheng, Rui and Wu, Yushan and Lin, Hao and Gan, Huatian and Zhang, Hu},
title = {Diagnosis and management of inflammatory bowel disease},
journal = {Journal of Evidence-Based Medicine},
year = {2024},
volume = {17},
number = {2},
pages = {409--433},
doi = {10.1111/jebm.12626}
}
EUVIMED